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http:WHAT THIS PAPER ADDS
In patients with a ruptured abdominal aortic aneurysm (RAAA), prediction models could support the decision to
select surgical or conservative treatment. In the present study the prediction model “updated GAS” most
accurately predicted death, and accuracy was further improved after recalibration. In future clinical practice, the
predictions can be used for case mix comparison between hospitals and tailoring the prognosis for patients and
relatives. However, the updated GAS was insufﬁciently accurate to identify patients who would die despite
intervention. Therefore, future studies should aim to improve the identiﬁcation of these high risk patients to
support the decision to withhold intervention.Objective: Prediction of survival after intervention for ruptured abdominal aortic aneurysms (RAAA) may support
case mix comparison and tailor the prognosis for patients and relatives. The objective of this study was to assess
the performance of four prediction models: the updated Glasgow Aneurysm Score (GAS), the Vancouver scoring
system, the Edinburgh Ruptured Aneurysm Score (ERAS), and the Hardman index.
Design, materials, and methods: This was a retrospective cohort study in 449 patients in ten hospitals with a
RAAA (intervention between 2004 and 2011). The primary endpoint was combined 30 day or in hospital death.
The accuracy of the prediction models was assessed for discrimination (area under the curve [AUC]). An AUC
>0.70 was considered sufﬁciently accurate. In studies with sufﬁciently accurate discrimination, correspondence
between the predicted and observed outcomes (i.e. calibration) was recalculated.
Results: The AUC of the updated GAS was 0.71 (95% conﬁdence interval [CI] 0.66e0.76), of the Vancouver score
was 0.72 (95% CI 0.67e0.77), and of the ERAS was 0.58 (95% CI 0.52e0.65). After recalibration, predictions by
the updated GAS slightly overestimated the death rate, with a predicted death rate 60% versus observed death
rate 54% (95% CI 44e64%). After recalibration, predictions by the Vancouver score considerably overestimated
the death rate, with a predicted death rate 82% versus observed death rate 62% (95% CI 52e71%). Performance
of the Hardman index could not be assessed on discrimination and calibration, because in 57% of patients
electrocardiograms were missing.
Conclusions: Concerning discrimination and calibration, the updated GAS most accurately predicted death after
intervention for a RAAA. However, the updated GAS did not identify patients with a 95% predicted death rate,
and therefore cannot reliably support the decision to withhold intervention.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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The overall death rate in patients with a ruptured aneurysm
of the abdominal aorta (RAAA) is approximately 74% (95%
conﬁdence interval [CI] 72e77%).1 In patients reaching the
hospital and undergoing intervention, the death rate ranges
between 24% and 49%.2e4 Surgeons have proposed dis-
tinguishing between those who would potentially beneﬁt
from surgery, and those in whom it might be better to
withhold intervention, for example after cardiopulmonary
resuscitation.5e9 In current clinical practice, the decision to
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evaluation of the patients’ clinical condition, the surgeon’s
experience, and the wishes of the patient. It is a subjective
interpretation of a harsh reality by the doctor, the patient,
and the relatives. A prediction model is a more standardized
and objective way to evaluate the chances of successful
intervention and might be helpful at these moments of vital
choices. Further beneﬁts of prediction models lie in case
mix comparison between hospitals and a tailored prognosis
for patients and relatives.
Several models have been developed to predict death
after intervention in patients with a RAAA: the Glasgow
Aneurysm Score (GAS),10 the Vancouver scoring system,11
the Edinburgh Ruptured Aneurysm Score (ERAS),12 and
the Hardman index.6 These scoring systems were initially
designed before the introduction of endovascular aneurysm
repair (EVAR). Nowadays, EVAR is being carried out
increasingly.2 Only the GAS has been updated to the era of
EVAR by the addition of a variable for type of
intervention.13
The primary objective of the present study was to assess
the accuracy of the updated GAS (the model including dif-
ferentiation between EVAR and OR), the Vancouver score,
the ERAS, and the Hardman index in predicting death. Only
extremely reliable models, those predicting death accu-
rately in more than 95% of cases, may be useful in clinical
decision making. A secondary objective was the assessment
of accuracy in patients with a predicted death rate of 95%
in whom withholding intervention might be considered.MATERIALS AND METHODS
A retrospective study was conducted in all consecutive
surgically treated patients with a RAAA in the Amsterdam
ambulance region between May 2004 and February 2011.
The present study was carried out as a sequel to the pre-
viously published Amsterdam Acute Aneurysm Trial.14 Other
details and analyses of this cohort have been published
previously.14,15 None of these previous studies aimed to
validate prediction models for patients with a RAAA. The
Amsterdam ambulance region covers an area of 1025 km2
with 1.38 million inhabitants.16 During the inclusion period,
care for patients with a RAAA was centralized in two uni-
versity hospitals and one teaching hospital in cooperation
with seven regional hospitals. All patients with a RAAA in all
ten hospitals of the region were registered prospectively by
the vascular surgeons, and included in the present study.
Patients with a previous aortic reconstruction, a RAAA with
associated trauma or aortoenteric ﬁstula, were excluded.
The primary endpoint was the combined 30 day or in
hospital death rate. Compared with some previous valida-
tion studies of the prediction models, in hospital death was
added to the deﬁnition; from a patients’ perspective the
ultimate goal is survival and being discharged. Approval
from a medical ethics committee was not needed because
of the observational design. This study adhered to the
STrengthening the Reporting of Observational studies in
Epidemiology (STROBE) guidelines.17Updated GAS
The updated GAS score was calculated with the formula:
age (years) þ 7 for cardiac comorbidity (deﬁned as previous
history of myocardial infarction, cardiac surgery, angina
pectoris or arrhythmia) þ 10 for cerebrovascular comor-
bidity (deﬁned as previous history of stroke or transient
ischemic attack) þ 17 for shock (deﬁned as an in hospital
systolic blood pressure <80 mmHg) þ 14 for renal insufﬁ-
ciency (deﬁned as a pre-operative serum creatinine
>160 mmol/L) þ 7 for OR (Fig. S1, online supplement).
Vancouver score
The Vancouver score was calculated with the formula: age
(years)*0.062 þ loss of consciousness (yes ¼ 1/no ¼ 1)
*1.14 þ cardiac arrest (yes ¼ 1/no ¼ 1)*0.6 (Fig. S2,
online supplement).
ERAS
The ERAS score was calculated with the formula: þ1 for
best recorded in hospital Glasgow coma scale (GCS)
<15, þ1 for in hospital systolic blood pressure
<90 mmHg, þ1 for pre-operative hemoglobin level
<5.6 mmol/L. A score of 0 or 1 corresponded with a pre-
dicted death rate of 30%, a score of 2 with a predicted
death rate of 50%, and a score of 3 with a predicted death
rate of 80%.
Hardman index
The Hardman index was calculated with the formula: þ1 for
age >76 years, þ1 for in hospital loss of consciousness, þ1
for a pre-operative serum creatinine >190 mmol/L, þ1 for
pre-operative serum hemoglobin level <5.6 mmol/L, þ1 for
electrocardiographic (ECG) ischemia (deﬁned as ST segment
depression greater than 1 millimeter or an associated T
wave change determined by a senior cardiologist [RJGP]). A
score of 3 or more corresponded with a predicted death
rate of 100%.
Data collection and statistical analysis
Data were collected from the medical records by the ﬁrst
and second authors. Data entry was done using Microsoft
Access 2003 (Microsoft Corporation, Redmond, WA, USA)
using ﬁeld limits, univariate and multivariate checks. A valid
way of coping with missing values is by imputation.18
Missing data were imputed for the variables blood pres-
sure, hemoglobin, creatinine, cardiac comorbidity, cere-
brovascular comorbidity, resuscitation, loss of
consciousness, and GCS. Multiple imputation was done
creating ten datasets. Age, sex, renal and pulmonary co-
morbidity, death, and the above mentioned imputed vari-
ables were used as predictors in the imputation model.
Baseline characteristics and prediction model scores are
reported in both the original dataset and in the imputed
datasets (Tables 1 and 2).
The statistical analysis and the imputation procedure
were done using IBM SPSS Statistics 19.0 (SPSS Inc.,
Table 1. Baseline pre-operative characteristics.
Pre-operative
variable
Original data Imputed data
Median (IQR) Missing data % Median (IQR)
Age in years 76 (69e80) 0 e
Lowest in
hospital SBP
in mmHg
90 (70e125) 11 (48/449) 90 (70e125)
Hemoglobin at
ER in mmol/L
7.0 (5.9e8.0) 1 (5/449) 7 (5.9e8.0)
Creatinine at
ER in mmol/L
106 (86e133) 3 (14/449) 107 (87e134)
% (Number) Missing data % % (Number)
Male:female 80:20 (360:89) 0 e
Cardiac
comorbidity
42 (184/435) 3 (14/449) 43 (191/449)
Cerebrovascular
comorbidity
15 (67/433) 4 (16/449) 15 (69/449)
In hospital
cardiopulmonary
resuscitation
11 (46/429) 4 (20/449) 12 (52/449)
In hospital loss
of consciousness
21 (81/388) 14 (61/449) 21 (96/449)
Best recorded
Glasgow Coma
Scale <15
17 (63/372) 17 (77/449) 18 (82/449)
ECG ischemia 21 (40/192) 57 (257/449) e
EVAR:OR 15:85 (69:380) 0 e
RAAA ¼ ruptured abdominal aortic aneurysm; SD ¼ standard
deviation; SBP ¼ systolic blood pressure; IQR ¼ interquartile
range; ER ¼ emergency room; EVAR ¼ endovascular aneurysm
repair; OR ¼ open repair, ECG ¼ electrocardiogram.
12 S.C. van Beek et al.Armonk, NY, USA) and R (The R Foundation for Statistical
Computing, Boston, MA, USA). Continuous data were
described by the mean with corresponding standard devi-
ation (SD) for data normally distributed, and by the median
with corresponding interquartile range (IQR) for data with
skewed distribution. The statistical analysis comprised ﬁve
steps. First, the accuracy of the predictions was determined
with regard to overall performance and discrimination.19Table 2. The outcomes and distribution in the original dataset and
the imputed dataset of the GAS, the updated GAS, the Vancouver
score and the ERAS.
Prediction model Original dataset Imputed
datasetMissing data
% (number)
Updated GAS,
mean (SD)
93 (15) 14 (64/449) 93 (15)
Vancouver,
median (IQR)
3.10
(2.66e3.72)
14 (64/449) 3.10
(2.66e3.74)
% (number) Missing data
% (number)
% (number)
ERAS score 1 79 (274/349) 22 (100/449) 77 (345/449)
2 17 (61/349) 19 (85/449)
3 4 (14/349) 4 (19/449)
SD ¼ standard deviation; GAS ¼ Glasgow Aneurysm Score;
ERAS ¼ Edinburgh Ruptured Aneurysm Score.Overall performance represents the squared difference
between the predicted outcome and actual outcome, and
was assessed using the Brier Score. The Brier Score should
be as close to 0 as possible and the threshold for a non-
informative model was calculated to be at 0.23. Discrimi-
nation is the ability of a model to distinguish between dying
and surviving patients and was assessed using the area
under the receiver operating characteristics curve (AUC). An
AUC >0.70 was considered sufﬁciently accurate. Second, in
the models with an AUC >0.70, the calibration of the
predictions was determined. Calibration refers to the
agreement between the predicted and observed death rate.
Calibration was assessed by dividing all patients into ﬁve
comparable quintiles: 0e20%, >20e40%, >40e60%,
>60e80% and >80e100%. Because patients with equal
predictions were categorized in the same quintile, the sizes
of the quintiles differed slightly between the several pre-
diction models. Subsequently, the mean predicted death
rate per quintile was plotted with the corresponding mean
observed death rate. In addition, the Hosmer-Lemeshow
(HL) chi-square test was done to compare the observed
and predicted death rates. In the HL test p < .05 reﬂects a
signiﬁcant difference between the predicted and observed
death rate which is a poor calibration. Third, the models
with an AUC >0.70 and an HL test p < .05 were recalibrated
using the ‘calibration intercept method’.20 Fourth, a sub-
group analysis was done in patients with a predicted death
rate of 95% to assess the accuracy in high risk patients in
whom withholding intervention might be considered. Fifth,
the accuracy of the prediction models was determined in
patients treated with EVAR. In this second subgroup anal-
ysis, the threshold of the Brier score for a non-informative
model was calculated to be at 0.20.
RESULTS
Of 539 patients with a RAAA in the greater Amsterdam
region, 66 did not have an intervention and 24 had to be
excluded because of other reasons (Fig. 1). The reasons to
refrain from intervention were predominantly shock or
resuscitation with an expected low chance of survival
(n ¼ 20), patient or patient’s family decision (n ¼ 17), or
unknown (n ¼ 17). The updated GAS, the Vancouver score,
and the ERAS of these patients without intervention is
shown in the online supplement (Table S3, online
supplement). The baseline characteristics of the 449 pa-
tients included in the analysis are shown in Table 1. Sixty-
nine patients were treated with EVAR and 380 patients
were treated with OR. The death rate was 36% (160/449,
95% CI 31e40).Updated GAS
The mean updated GAS score was 93 (standard deviation
(SD) 15) (Table 2). The Brier Score was 0.21 and the AUC
was 0.71 (95% CI 0.66e0.76). The calibration plot showed
an overestimation of the death rate in patients with a
predicted death rate >50% (HL test p ¼ .01) (Fig. 2). In the
quintile of patients with a mean predicted death rate of
Figure 1. Flowchart of inclusion and exclusion in the analysis. RAAA ¼ ruptured abdominal aortic aneurysm; CI ¼ 95% conﬁdence interval.
Figure 2. The calibration plots of the updated GAS before and after
recalibration. The predicted death rate is plotted with the corre-
sponding death rate and surrounding 95% conﬁdence interval. The
interrupted black line indicates ideal calibration. The p corresponds
to the Hosmer-Lemeshow (HL) chi-square test. GAS ¼ Glasgow
Aneurysm Score.
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After recalibration, the plot slightly improved, although
there was still a statistically signiﬁcant deviation between
the predicted and observed risks (HL test p ¼ .04, Fig. 3). In
the quintile of patients with a mean predicted death rate of
60%, the observed death rate was 54% (95% CI 44e64)
after recalibration.
Subgroup analysis to assess the accuracy in high risk
patients showed that no patients had a predicted death
rate 95%. In patients treated with EVAR, the Brier Score
was 0.17, the AUC was 0.78 (95% CI 0.66e0.90), and in the
HL test p was .18.Vancouver score
The median Vancouver score was 3.10 (interquartile range
2.66e3.72) (Table 2). The Brier Score was 0.22 and the AUC
was 0.72 (95% CI 0.67e0.77). With regard to calibration, in
the quintile of patients with a mean predicted death rate of
33%, the observed death rate was 21% (95% CI 14e31%),
and in the quintile of patients with a mean predicted deathFigure 3. The formula to calculate the predicted death rate using
the updated GAS after recalibration. GAS ¼ Glasgow Aneurysm
Score.
14 S.C. van Beek et al.rate of 89%, the observed death rate was 62% (95% CI 52e
71%). Hence, the calibration plot showed an overestimation
of death (HL test p < .01) (Fig. 3). After recalibration, this
overestimation decreased minimally (HL test p < .01, Fig.
4). In high risk patients there was a signiﬁcant over-
estimation of the observed risk by the recalibrated model.
In the quintile of patients with a mean predicted death rate
of 82%, the observed death rate was 62% (95% CI 52e71).
Subgroup analysis to assess the accuracy in high risk
patients showed that of 21 patients with a predicted death
rate 95%, 18 patients died. In patients treated with EVAR,
the Brier Score was 0.19, the AUC was 0.77 (95% CI 0.64e
0.90), and the HL test p was .03.
ERAS
The distribution of patients per ERAS outcome is shown in
Table 2. The Brier Score was 0.23 and the AUC was 0.58
(95% CI 0.52e0.64). Calibration was not assessed because
of an AUC <0.70. Subgroup analysis to assess the accuracy
in high risk patients showed that no patients had a pre-
dicted death rate 95%. In patients treated with EVAR, the
Brier Score was 0.20 and the AUC was 0.55 (95% CI 0.50e
0.60).
Hardman index
In 57% (257/449), the pre-operative ECGs were missing.
Therefore, the Hardman index was excluded from the
analysis.
DISCUSSION
The present study shows that following intervention for a
RAAA, the updated GAS predicted death most accurately forFigure 4. The calibration plots of the Vancouver score before and
after recalibration. The predicted death rate is plotted with the
corresponding death rate and surrounding 95% conﬁdence inter-
val. The interrupted black line indicates ideal calibration. The p
corresponds to the Hosmer-Lemeshow (HL) chi-square test.both discrimination and calibration. The present study ex-
pands on previous studies externally validating the updated
GAS, the Vancouver score, and the ERAS. First, a cut-off
value of patients was set in whom withholding interven-
tion might be considered. In this way, it was aimed to assess
the additional value of the prediction models in clinical
practice. Second, the number of patients included (n ¼ 449)
was higher than the previous largest study (n ¼ 201).13
Finally, the updated GAS and Vancouver score were recali-
brated to improve accuracy in the era of EVAR. Because of
the large number of missing ECGs, no deﬁnite conclusions
could be drawn for the Hardman index.
Decision making
The decision to withhold intervention in patients with a
RAAA can be very difﬁcult. Only extremely reliable models
can be useful in clinical decision making and in identifying
patients in whom withholding intervention might be
considered. For this purpose, a cut-off value for the pre-
dicted death rate was set at 95%. If the death rate was to
be predicted accurately at 95%, the number needed to treat
(NNT) would be 20. This cut-off value is arbitrary and could
also have been 90% (NNT of 10) or 99% (NNT of 100).
Different cut-off values can be used depending on the
clinical situation. None of the prediction models met the
criterion of identifying patients in whom to withhold
intervention. This disappointing conclusion is in agreement
with previous validation studies.21e23 Currently, the pre-
diction models have insufﬁcient accuracy to evaluate the
chances of successful intervention and future studies should
focus on improvement towards this aim. The usefulness of
current prediction models lies in case mix comparisons
between hospitals, and in a tailored prognosis for patients
and relatives.
Updated GAS
The updated GAS predicted death most accurately for both
discrimination and calibration. Several other studies have
validated the GAS.13,22e26 In the only previous study
including patients treated with EVAR, the AUC was 0.70
(95% CI 0.62e0.77).13 The calibration of the updated GAS
was not assessed in this previous study. The strength of the
previous validation (201 patients included, multicenter,
prospective, including EVAR and OR)13 conﬁrms the
conclusion that the updated GAS is the most accurate in
predicting death after intervention for a RAAA. If clinicians
consider their patients to be comparable with those
included in the present study, the model as shown in Fig. 3
can be used to predict the risk of dying after intervention.
Vancouver score
The Vancouver score discriminated sufﬁciently accurately,
but even after recalibration its predictions still over-
estimated the death rate considerably. These results are in
accordance with previous disappointing results on discrim-
ination,27 but in conﬂict with previous fairly accurate results
on calibration.23 Therefore, the accuracy of the Vancouver
External Validation of Models Predicting Survival 15score has not yet been proven and the present authors
prefer the updated GAS.
ERAS
The prediction of death by the ERAS was insufﬁciently ac-
curate. These results are in conﬂict with one validation
study with sufﬁciently accurate discrimination,25 but in
accordance with another validation study with insufﬁciently
accurate discrimination.23 Concerning calibration, one pre-
vious validation reported an observed death rate of 50% in
patients with a predicted death rate of 80% (estimated from
ﬁgure).23 Because results regarding the ERAS are conﬂicting,
the present authors question its precision.
Hardman index
The Hardman index was excluded from the analysis because
data on one variable, presence of electrocardiographic
(ECG) ischemia, were missing in 57% of patients. The
missing ECGs are a drawback of the present study, and also
of the scoring system. Most surgical trainees and vascular
surgeons do not know how to interpret an ECG with sufﬁ-
cient precision to use it as a variable in a prediction model.
From a cardiac perspective, acute ischemia deﬁned by ST
segment depression greater than 1 millimeter or an asso-
ciated T wave change is an oversimpliﬁcation of the great
diagnostic value of an ECG. Based on these considerations,
the present authors are convinced that in their clinical
practice the contribution of a pre-operative ECG is limited
and, consequently, that the Hardman index is not a useful
prediction model.
EVAR
The predictions by the updated GAS and the Vancouver
score appeared slightly more accurate in patients treated
with EVAR compared with all patients. The accuracy of the
ERAS appeared similar for patients treated with EVAR
compared with all patients, Recently published randomized
clinical trials reported comparable death rates after EVAR
and OR.28,29 This indicates that the risk proﬁles are based
on the same pre-operative variables and that the accuracy
of the prediction models probably does not differ sub-
stantially between both interventions. Also, because of a
low event rate (19/69) and wider conﬁdence intervals in
patients treated with EVAR, the present authors are reluc-
tant to draw deﬁnite conclusions regarding the accuracy in
patients treated with EVAR separately.
Limitations
An important limitation of the present study was the
exclusion of the Hardman index. Two other prediction
models have been described in the literature, the RAAA-
physiological and operative severity score for enumeration
of mortality and morbidity (RAAA-POSSUM)30 and the
Vascular Study Group of New England (VSGNE) RAAA
score.23 The RAAA-POSSUM was not included in the present
study because of its complexity including chest X-rayexamination, and hence low clinical applicability. The VSGNE
RAAA score was not included in the present study because
of the use of an intra-operative variable, thereby making
predictions prior to the intervention impossible. In short,
the authors consider the variables of the three excluded
prediction models unsuitable for fast evaluation of the
chances of successful intervention.
Another limitation of the present study was retrospective
data collection. Probably, the variables ‘best recorded in
hospital Glasgow coma scale’ for the ERAS and ‘loss of
consciousness’ for the Vancouver score contain imprecise
data. Another limitation was the amount of missing data
(Tables 1 and 2). This is a consequence of the acute char-
acter of the disease. The authors coped with this problem
by multiple imputation. Death was included as a predictor
in the imputation model to correct for the bias that the
most missing data were in patients who died.
Conclusions
The updated GAS most accurately predicted death after
intervention for a RAAA. However, the updated GAS did not
identify patients with a predicted death rate 95%, and
therefore cannot reliably support the decision to withhold
intervention.
ACKNOWLEDGEMENT
The authors wish to thank Susan van Dieren for statistical
support.
CONFLICT OF INTEREST
None.
FUNDING
Partial funding was provided by the Dutch Heart Foundation
(project: 2002B197) and the AMC Foundation. The sponsor
had no involvement in the study design, in the collection,
analysis and interpretation of data; in the writing of the
manuscript; and in the decision to submit the manuscript
for publication.
APPENDIX A. SUPPLEMENTARY MATERIAL
Supplementary material related to this article can be found
online at http://dx.doi.org/10.1016/j.ejvs.2014.10.012.
REFERENCES
1 Reimerink JJ, van der Laan MJ, Koelemay MJ, Balm R,
Legemate DA. Systematic review and meta-analysis of
population-based mortality from ruptured abdominal aortic
aneurysm. Br J Surg 2013;100(11):1405e13.
2 Mani K, Lees T, Beiles B, Jensen LP, Venermo M, Simo G, et al.
Treatment of abdominal aortic aneurysm in nine countries
2005e2009: a vascunet report. Eur J Vasc Endovasc Surg
2011;42(5):598e607.
3 Hoornweg LL, Storm-Versloot MN, Ubbink DT, Koelemay MJ,
Legemate DA, Balm R. Meta analysis on mortality of ruptured
abdominal aortic aneurysms. Eur J Vasc Endovasc Surg
2008;35(5):558e70.
16 S.C. van Beek et al.4 Rayt HS, Sutton AJ, London NJ, Sayers RD, Bown MJ.
A systematic review and meta-analysis of endovascular repair
(EVAR) for ruptured abdominal aortic aneurysm. Eur J Vasc
Endovasc Surg 2008;36(5):536e44.
5 Hewin DF, Campbell WB. Ruptured aortic aneurysm: the de-
cision not to operate. Ann R Coll Surg Engl 1998;80(3):221e5.
6 Hardman DT, Fisher CM, Patel MI, Neale M, Chambers J,
Lane R, et al. Ruptured abdominal aortic aneurysms: who
should be offered surgery? J Vasc Surg 1996;23(1):123e9.
7 Biancari F, Venermo M. Open repair of ruptured abdominal
aortic aneurysm in patients aged 80 years and older. Br J Surg
2011;98(12):1713e8.
8 Prance SE, Wilson YG, Cosgrove CM, Walker AJ, Wilkins DC,
Ashley S. Ruptured abdominal aortic aneurysms: selecting pa-
tients for surgery. Eur J Vasc Endovasc Surg 1999;17(2):129e32.
9 Greeven AP, Bouwman LH, Smeets HJ, van Baalen JM,
Hamming JF. Outcome of patients with ruptured abdominal
aortic aneurysm after cardiopulmonary resuscitation. Acta Chir
Belg 2011;111(2):78e82.
10 Samy AK, Murray G, MacBain G. Glasgow aneurysm score.
Cardiovasc Surg 1994;2(1):41e4.
11 Chen JC, Hildebrand HD, Salvian AJ, Taylor DC, Strandberg S,
Myckatyn TM, et al. Predictors of death in nonruptured and
ruptured abdominal aortic aneurysms. J Vasc Surg 1996;24(4):
614e20.
12 Tambyraja A, Murie J, Chalmers R. Predictors of outcome after
abdominal aortic aneurysm rupture: Edinburgh Ruptured
Aneurysm Score. World J Surg 2007;31(11):2243e7.
13 Visser JJ, Williams M, Kievit J, Bosch JL. Prediction of 30 day
mortality after endovascular repair or open surgery in patients
with ruptured abdominal aortic aneurysms. J Vasc Surg
2009;49(5):1093e9.
14 van Beek SC, Reimerink JJ, Vahl A, Wisselink W, van Geloven N,
Legemate DA, et al. Effect of regional cooperation on outcomes
from ruptured abdominal aortic aneurysm. Br J Surg
2014;101(7):794e801.
15 van Beek SC, Reimerink JJ, Vahl AC, Wisselink W, Reekers JA,
Legemate DA, et al. Outcomes after open repair for ruptured
abdominal aortic aneurysms in patients with friendly versus
hostile aortoiliac anatomy. Eur J Vasc Endovasc Surg
2014;47(4):380e7.
16 Statistics Netherlands. http://www.cbs.nl/en-GB/menu/home/
default.htm; 2010.
17 Von EE, Altman DG, Egger M, Pocock SJ, Gotzsche PC,
Vandenbroucke JP. The Strengthening the Reporting of Obser-
vational Studies in Epidemiology (STROBE) statement: guide-
lines for reporting observational studies. PLoS Med 2007;4(10):
e296.
18 Donders AR, van der Heijden GJ, Stijnen T, Moons KG. Review:
a gentle introduction to imputation of missing values. J Clin
Epidemiol 2006;59(10):1087e91.19 Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M,
Obuchowski N, et al. Assessing the performance of prediction
models: a framework for traditional and novel measures.
Epidemiology 2010;21(1):128e38.
20 Janssen KJ, Moons KG, Kalkman CJ, Grobbee DE, Vergouwe Y.
Updating methods improved the performance of a clinical
prediction model in new patients. J Clin Epidemiol 2008;61(1):
76e86.
21 Gatt M, Goldsmith P, Martinez M, Barandiaran J, Grover K, El-
Barghouti N, et al. Do scoring systems help in predicting sur-
vival following ruptured abdominal aortic aneurysm surgery?
Ann R Coll Surg Engl 2009;91(2):123e7.
22 Kurc E, Sanioglu S, Ozgen A, Aka SA, Yekeler I. Preoperative risk
factors for in hospital mortality and validity of the Glasgow
aneurysm score and Hardman index in patients with ruptured
abdominal aortic aneurysm. Vascular 2012;20(3):150e5.
23 Robinson WP, Schanzer A, Li Y, Goodney PP, Nolan BW,
Eslami MH, et al. Derivation and validation of a practical risk
score for prediction of mortality after open repair of ruptured
abdominal aortic aneurysms in a U.S. regional cohort and
comparison to existing scoring systems. J Vasc Surg 2013;57(2):
354e61.
24 Kapma M, Kahmann O, Van Stijn I, Zeebregts CJ, Vahl A. Eval-
uation of risk prediction models, V-POSSUM and GAS, in pa-
tients with acute abdominal aortic rupture treated with EVAR
or an open procedure. J Cardiovasc Surg (Torino) 2014 Jan 16
[Epub ahead of print].
25 Tambyraja AL, Lee AJ, Murie JA, Chalmers RT. Prognostic
scoring in ruptured abdominal aortic aneurysm: a prospective
evaluation. J Vasc Surg 2008;47(2):282e6.
26 Korhonen SJ, Ylonen K, Biancari F, Heikkinen M, Salenius JP,
Lepantalo M. Glasgow Aneurysm Score as a predictor of im-
mediate outcome after surgery for ruptured abdominal aortic
aneurysm. Br J Surg 2004;91(11):1449e52.
27 Leo E, Biancari F, Nesi F, Pogany G, Bartolucci R, De PF, et al.
Risk-scoring methods in predicting the immediate outcome
after emergency open repair of ruptured abdominal aortic
aneurysm. Am J Surg 2006;192(1):19e23.
28 Reimerink JJ, Hoornweg LL, Vahl AC, Wisselink W, van den
Broek TA, Legemate DA, et al. Endovascular repair versus open
repair of ruptured abdominal aortic aneurysms: a multicenter
randomized controlled trial. Ann Surg 2013;258(2):248e56.
29 Powell JT, Sweeting MJ, Thompson MM, Ashleigh R, Bell R,
Gomes M, et al. Endovascular or open repair strategy for
ruptured abdominal aortic aneurysm: 30 day outcomes from
IMPROVE randomised trial. BMJ 2014;348:f7661.
30 Prytherch DR, Sutton GL, Boyle JR. Portsmouth POSSUM
models for abdominal aortic aneurysm surgery. Br J Surg
2001;88(7):958e63.
